Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

As Annals of Oncology marks its 35th anniversary, its mission remains focused on publishing research that advances cancer treatment and improves patient outcomes. 

By fostering innovation in oncology, the journal aims to make a tangible difference in the field.

Annals of Oncology is the official journal of the European Society for Medical Oncology (ESMO) and the Japanese Society of Medical Oncology (JSMO). Since its launch in 1989, the journal has been a key resource for oncology research, publishing peer-reviewed articles on innovative cancer treatments and new emerging fields, including among others, precision oncology.

It covers a variety of subjects within the multidisciplinary approach to cancer care and remains a vital platform in the rapidly evolving global oncology landscape

Global Reach and Influence

Annals of Oncology stands out for its international scope, supported by a global editorial board of leading oncology experts. This broad representation ensures that the journal captures the latest advances from around the world, offering critical insights for oncologists, researchers, and healthcare professionals.

Annals-of-Oncology-Celebrating-35-Years-Global-Readership

Contribution to ESMO Congress 2024

The journal’s role as a leading voice in oncology was underscored at the ESMO Congress 2024 in Barcelona, where it published 13 concomitant articles. These articles highlighted key research findings presented at the congress, demonstrating Annals of Oncology's commitment to timely dissemination of important research and its contribution to global oncology discussions.

The Future of Annals of Oncology

Looking ahead, Annals of Oncology remains dedicated to providing high-quality, impactful research that helps shape the future of cancer treatment. By staying at the forefront of developments in personalised medicine and emerging therapies, the journal will continue to be a valuable resource for the global oncology community. As it enters its fourth decade, Annals of Oncology is well-positioned to remain a key player in the ongoing advancements in cancer research and patient care.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.